PHARMACY CARE NICOTINE LOZENGES 2mg nicotine (as nicotine polacrilex) lozenge blister pack

Nchi: Australia

Lugha: Kiingereza

Chanzo: Department of Health (Therapeutic Goods Administration)

Viambatanisho vya kazi:

nicotine polacrilex, Quantity: 13.33 mg (Equivalent: nicotine, Qty 2 mg)

Inapatikana kutoka:

Orion Laboratories Pty Ltd T/A Perrigo Australia

INN (Jina la Kimataifa):

Nicotine polacrilex

Dawa fomu:

Tablet, uncoated

Tungo:

Excipient Ingredients: aspartame; xanthan gum; mannitol; sodium alginate; sodium carbonate; magnesium stearate; potassium bicarbonate; Flavour

Njia ya uendeshaji:

Buccal

Vitengo katika mfuko:

36, 156, 168, 96, 132, 144, 108, 120, 72

Dawa ya aina:

Not Scheduled after consideration by Committee

Matibabu dalili:

Relief of nicotine withdrawal symptoms including cravings associated with smoking cessation. Nicotine Lozenges may also be used as part of a smoking reduction strategy by smokers who are unable or not ready to stop smoking abruptly as a step towards stopping smoking. If possible, when stopping smoking, should be used in conjunction with behavioural support program.

Bidhaa muhtasari:

Visual Identification: Cream/white embossed biconvex round tablet with an odour of peppermint. Embossed with 'L344' on one face.; Container Type: Blister Pack; Container Material: PVC/PCTFE (Aclar)/Al; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius

Idhini hali ya:

Licence status A

Idhini ya tarehe:

2014-12-16